Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -149.78% is 22% below its 5-year average of -122.97%, around the middle of its 5-year range (-327.85%–-60.22%).
22.70% above its 12-month average of -193.77%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -327.85%.
OPERATING MARGIN
-149.78%
OPERATING MARGIN AVG TTM
-193.77%
OPERATING MARGIN AVG 3Y
-143.81%
OPERATING MARGIN AVG 5Y
-122.97%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+22.70%
CURRENT VS 3Y AVG
-4.15%
CURRENT VS 5Y AVG
-21.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 748 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Elutia Inc
Market Cap
$35.15M
Operating Margin
-149.78%
TTM Avg
-193.77%
3Y Avg
-143.81%
5Y Avg
-122.97%
Market Cap
$34.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$34.58M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1396.17%
Market Cap
$34.33M
Operating Margin
-6.58%
TTM Avg
-2.44%
3Y Avg
-1.06%
5Y Avg
0.55%
Market Cap
$36.63M
Operating Margin
-17.45%
TTM Avg
-136.53%
3Y Avg
-3170.70%
5Y Avg
-2922.37%
Market Cap
$36.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-343.01%
Market Cap
$33.23M
Operating Margin
-4024.93%
TTM Avg
-3142.43%
3Y Avg
-1888.50%
5Y Avg
-1749.64%
Market Cap
$32.71M
Operating Margin
-36.42%
TTM Avg
-233.99%
3Y Avg
-181.69%
5Y Avg
-124.85%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elutia Inc (ELUT) | $35.15M | -149.78% | -193.77% | -143.81% | -122.97% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | 0.00% | 0.00% | 0.00% | -1396.17% |
| DocGo Inc. (DCGO)vs › | $35.92M | -27.67% | -11.51% | -3.91% | -4.42% |
| Accuray Incorporated (ARAY)vs › | $34.33M | -6.58% | -2.44% | -1.06% | 0.55% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | -17.45% | -136.53% | -3170.70% | -2922.37% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.70M | 0.00% | 0.00% | 0.00% | -343.01% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.23M | -4024.93% | -3142.43% | -1888.50% | -1749.64% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.71M | -36.42% | -233.99% | -181.69% | -124.85% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.76M | 0.00% | 0.00% | 0.00% | -324.45% |
Gross Margin
57.8%
Operating Margin
-149.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -327.85% |
| 2026-03-31 | -184.39% |
| 2025-12-31 | -167.87% |
| 2025-09-30 | -131.06% |
| 2025-06-30 | -157.67% |
| 2025-03-31 | -131.38% |
| 2024-12-31 | -154.21% |
| 2024-09-30 | -172.75% |
| 2024-06-30 | -135.27% |
| 2024-03-31 | -126.67% |
| 2023-12-31 | -144.82% |
| 2023-09-30 | -120.30% |
| 2023-06-30 | -99.34% |
| 2023-03-31 | -130.46% |
| 2022-12-31 | -69.82% |
| 2022-09-30 | -153.31% |
| 2022-06-30 | -64.74% |
| 2022-03-31 | -60.22% |
| 2021-12-31 | -71.47% |
| 2021-09-30 | -60.74% |
